Jupiter Neurosciences (JUNS) Gross Margin (2026)
Jupiter Neurosciences' (JUNS) quarterly Gross Margin came in at 86.88% in Q2 2026.
Powered by 
Analysis
Jupiter Neurosciences (JUNS) Gross Margin (2026) Analysis & Trends
Jupiter Neurosciences (JUNS) has reported Gross Margin for 1 consecutive years, with 86.88% the latest figure, recorded in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.23 Bn | 68.86 Bn | 3.30 Bn | 61.48% |
| 2 | Kenvue | 34.13 Bn | 33.02 Bn | 2.30 Bn | 58.18% |
| 3 | Kimberly Clark | 32.73 Bn | 31.77 Bn | 1.60 Bn | 38.27% |
| 4 | Bath & Body Works | 3.77 Bn | 2.98 Bn | 692.00 Mn | 45.71% |
| 5 | Prestige Consumer Healthcare | 2.27 Bn | 2.21 Bn | - | - |
| 6 | Perrigo | 1.89 Bn | 1.49 Bn | 313.90 Mn | 30.69% |
| 7 | Herbalife | 1.28 Bn | 905.45 Mn | 1.03 Bn | 77.67% |
| 8 | Edgewell Personal Care | 1.24 Bn | 840.59 Mn | 242.50 Mn | 42.54% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Jupiter Neurosciences | 1.75 Mn | 223,310.77 | 21,064.00 | 86.88% |